Company
Aptorum Group (NASDAQ / EURONEXT PARIS: APM) is a listed company engaged in Pharmaceutical and Biotechnology industry, dedicated to developing and commercializing a broad portfolio of projects under development of therapeutic and diagnostic technologies to tackle unmet medical needs. By amalgamating the Group's capabilities in both science and finance, our platform is committed to creating solutions for healthcare advancement in Asia and globally.
